Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Skin enzymes convert topical drugs into active forms, affecting drug effectiveness and safety.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

Finasteride metabolism varies by age, sex, and P450 inducers, with males processing it faster.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Data-driven methods can help understand microbiota's role in diseases and develop personalized treatments.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Skin health and diseases are closely linked to metabolic processes.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.